Slide 1: First Quarter 2022 Earnings
First Quarter 2022 Earnings April 27, 2022 1
Slide 2: Agenda
Agenda IDEX Business Overview Q1 2022 Financial Performance Segment Performance 2022 Guidance Summary Q&A IDEX Proprietary & Confidential 2
Slide 3: Replay Information
Replay Information • Dial toll–free: 877.660.6853 • International: 201.612.7415 • Conference ID: #13724803 • Log on to: www.idexcorp.com IDEX Proprietary & Confidential 3
Slide 4: Cautionary Statement
Cautionary Statement Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other
Slide 5: Business Update
Business Update IDEX Proprietary & Confidential 5
Slide 6: IDEX Overview
IDEX Overview Capitalizing on Robust Demand • Record Orders, Sales, and Backlog • Organic sales growth of 12% doubles expectations • Growth across all three segments Driving Operational Excellence • Managing the supply chain environment • Continued price capture amid inflation • Productivity initiat
Slide 7: Financials
Financials IDEX Proprietary & Confidential 7
Slide 8: IDEX Q1 2022 Financial Performance
IDEX Q1 2022 Financial Performance (Dollars in millions, excl. EPS) Sales Adjusted Earnings per Share* +12% Organic* 21% Increase $751 $1.96 $652 $1.62 Q1 2021 Q1 2022 Q1 2021 Q1 2022 Adjusted Operating Margin* Free Cash Flow* +70 bps 33% decrease 25.0% $95 $64 24.3% Q1 2021 Q1 2022 Q1 2021 Q1 2022
Slide 9: 2022 Adjusted Operating Income Walk
2022 Adjusted Operating Income Walk (Dollars in millions) 11 (0) 2 $ 188 25 (4) (4) $ 158 1Q'21 Organic Price/ Mix Growth Discretionary Acq/FX 1Q'22 Adj Op Income* Flow Thru Productivity/ Investments Adj Op Income * Inflation Flow through Organic flow Total flow @ PY GM% through ex through 45% Acq /
Slide 10: IDEX Segment Performance
IDEX Segment Performance Fluid & Metering Technology Health & Science Technology Fire & Safety / Diversified Q1 Revenue $272M / 36% of Total Q1 Revenue $315M / 42% of Total Q1 Revenue $165M / 22% of Total •Positive industrial book & ship •Strong secular growth trends •Dispensing strong performance •
Slide 11: 2022 Guidance Summary
2022 Guidance Summary Second Quarter Full Year Current Prior Current Guidance Guidance Guidance Organic Sales % Organic* 8-9% 5-8% 6-8% Operating Margin % Reported 23-23.5% ~24% ~24% Reported $1.69-$1.74 $6.70-$7.00 $6.87-$7.00 Earnings per Share Adjusted* $1.85-$1.90 $7.33-$7.63 $7.50-$7.63 Other M
Slide 12: Appendix
Appendix IDEX Proprietary & Confidential 12
Slide 13: Fluid & Metering Technologies
Fluid & Metering Technologies (Dollars in millions) Orders Sales Adjusted Operating Margin* +14% Organic* +11% Organic* +300 bps* $272 29.5% $289 $243 $250 26.5% Q1 2021 Q1 2022 Q1 2021 Q1 2022 Q1 2021 Q1 2022 Q1 Highlights: Q1 Sales Mix: Organic 11% Strong Industrial day rates Acquisition 2% Ag
Slide 14: Health & Science Technologies
Health & Science Technologies (Dollars in millions) Orders Sales Adjusted Operating Margin* +21% Organic* +16% Organic* -40 bps* $315 26.9% $381 $250 $291 26.5% Q1 2021 Q1 2022 Q1 2021 Q1 2022 Q1 2021 Q1 2022 Q1 Highlights: Q1 Sales Mix: Organic 16% Strong Life Sciences, Analytical Instrumentation
Slide 15: Fire & Safety / Diversified Products
Fire & Safety / Diversified Products (Dollars in millions) Orders Sales Adjusted Operating Margin* +12% Organic* +5% Organic* -340 bps* $188 $165 28.0% $171 $160 24.6% Q1 2021 Q1 2022 Q1 2021 Q1 2022 Q1 2021 Q1 2022 Q1 Sales Mix: Organic 5% Q1 Highlights: Dispensing strong demand within paint market
Slide 16: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures This information reconciles non-GAAP measures (denoted with a *) with the most directly comparable GAAP measure. (dollars in millions, except per share amounts) Reconciliation of the Change in Net Sales to Organic Net Sales Three Months Ended March 31, 2022 FMT HS
Slide 17: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures This information reconciles non-GAAP measures (denoted with a *) with the most directly comparable GAAP measure. (dollars in millions, except per share amounts) Reconciliation of Reported-to-Adjusted Operating Income and Margin Three Months Ended March 31, 2022 20
Slide 18: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures This information reconciles non-GAAP measures (denoted with a *) with the most directly comparable GAAP measure. (dollars in millions, except per share amounts) Reconciliation of Reported-to-Adjusted Net Income Three Months Ended March 31, 2022 2021 Reported net i
Slide 19: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures This information reconciles non-GAAP measures (denoted with a *) with the most directly comparable GAAP measure. (dollars in millions, except per share amounts) Reconciliation of Reported-to-Adjusted EPS Three Months Ended March 31, 2022 2021 Reported diluted EPS
Slide 20: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures This information reconciles non-GAAP measures (denoted with a *) with the most directly comparable GAAP measure. (dollars in millions, except per share amounts) Reconciliation of Cash Flows from Operating Activities to Free Cash Flow Three Months Ended March 31, 2
Slide 21: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures This information reconciles non-GAAP measures (denoted with a *) with the most directly comparable GAAP measure. (dollars in millions, except per share amounts) Reconciliation of Estimated 2022 EPS to Adjusted EPS Attributable to IDEX Guidance Second Quarter 2022